Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).

Kanazawa N, Ishii T, Takita Y, Nishikawa A, Nishikomori R

Open source

DOI
10.1186/s12969-023-00817-8
Published
2023 Apr 22
Container
Pediatric rheumatology online journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12969-023-00817-8,
  title = {Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).},
  author = {Kanazawa N and Ishii T and Takita Y and Nishikawa A and Nishikomori R},
  year = {2023},
  journal = {Pediatric rheumatology online journal},
  doi = {10.1186/s12969-023-00817-8},
  url = {https://doi.org/10.1186/s12969-023-00817-8}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
AU  - Kanazawa N
AU  - Ishii T
AU  - Takita Y
AU  - Nishikawa A
AU  - Nishikomori R
PY  - 2023
JO  - Pediatric rheumatology online journal
DO  - 10.1186/s12969-023-00817-8
UR  - https://doi.org/10.1186/s12969-023-00817-8
ER  - 

APA

N, K., T, I., Y, T., A, N., & R, N. (2023). Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).. Pediatric rheumatology online journal. https://doi.org/10.1186/s12969-023-00817-8

Source records